ESC & iPSC News Volume 18.25 | Jun 28 2023

    0
    42







    2023-06-28 | ESC & iPSC 18.25


    ESC & iPSC News by STEMCELL Technologies
    Vol. 18.25 – 28 June, 2023
    TOP STORY

    Self-Patterning of Human Stem Cells into Post-Implantation Lineages

    Scientists showed that human PSCs could be triggered to self-organize into three-dimensional structures that recapitulate some key spatiotemporal events of early human post-implantation embryonic development.
    [Nature]

    Abstract
    View tips on how to plan ahead and get the most out of your time in the lab.
    PUBLICATIONSRanked by the impact factor of the journal

    A Model of the Post-Implantation Human Embryo Derived from Pluripotent Stem Cells

    Researchers combined two types of extraembryonic-like cells generated by transcription factor overexpression with wildtype embryonic stem cells and promoted their self-organization into structures that mimic several aspects of the post-implantation human embryo.
    [Nature]

    AbstractPress Release

    Histone Exchange Sensors Reveal Variant Specific Dynamics in Mouse Embryonic Stem Cells

    Investigators defined the genome-wide occupancy and exchange pattern of canonical and non-canonical histone variants in mouse embryonic stem cells by genetically encoded exchange sensors.
    [Nature Communications]

    Full Article

    Functional Evaluation of Rare OASL Variants by Analysis of SLE Patient-Derived iPSCs

    To identify and elucidate the biological functions of rare variants underlying systemic lupus erythematosus (SLE), scientists conducted analyses of patient-derived iPSCs in combination with genetic analysis.
    [Journal Of Autoimmunity]

    AbstractGraphical Abstract

    Human Prostate Organoid Generation and the Identification of Prostate Development Drivers Using Inductive Rodent Tissues

    Researchers showed that hiPSCs can be differentiated into prostate organoids using neonatal rat seminal vesicle mesenchyme in vitro. The organoids could be used to study prostate development or modified to study prostate cancer.
    [Development]

    Abstract

    Syntaxin4, P-Cadherin, and CCAAT Enhancer Binding Protein β As Signaling Elements in the Novel Differentiation Pathway for Cultured Embryonic Stem Cells

    The forced overexpression of CCAAT enhancer binding protein β (C/EBPβ) led to the downregulation of brachyury and a significant upregulation of the smooth muscle cell-related gene ACTA2 in ESCs.
    [Biochemical And Biophysical Research Communications]

    Full ArticleGraphical Abstract

    Human Induced Pluripotent Stem Cell-Derived Pericytes as Scalable and Editable Source to Study Direct Lineage Reprogramming Into Induced Neurons

    Investigators introduced hiPSC-derived pericytes as a versatile and more uniform tool to study the pericyte-to-neuron conversion process.
    [Cellular Reprogramming]

    Abstract

    Generation of Induced Pluripotent Stem Cell Line (XWHNi002-a) from a Female with APP Gene Mutation

    A hiPSC line was generated from peripheral blood mononuclear cells isolated from a female with β-amyloid precursor protein (APP) gene mutation utilizing non-integrative Sendai virus.
    [Stem Cell Research]

    Full Article

    Generation of Two Induced Pluripotent Stem Cell Lines and the Corresponding Isogenic Controls from Parkinson’s Disease Patients Carrying the Heterozygous Mutations c.815G > a (p.R272Q) or c.1348C > T (p.R450C) in the RHOT1 Gene Encoding Miro1

    Fibroblasts from two Parkinson’s disease patients carrying either the heterozygous mutation c.815G > A or c.1348C > T in the RHOT1 gene, were converted into iPSCs using RNA-based and episomal reprogramming, respectively.
    [Stem Cell Research]

    Full Article
    He needed a better model system. So he invented a new organoid. Watch James Wells' webinar.
    REVIEWS

    Exploring the Potential of In Vivo Reprogramming for Studying Embryonic Development, Tissue Regeneration, and Organismal Aging

    Expression of the reprogramming factors that promote cellular reprogramming in vivo results in unique consequences that are not seen when cells are reprogrammed ex vivo, and can provide insights into development, tissue regeneration, cancer, and aging.
    [Current Opinion In Genetics & Development]

    Abstract
    INDUSTRY AND POLICY NEWS

    European Patent Office Grants ONK Therapeutics’ Foundational Patent for CISH Knockout in NK Cells for Use in Cancer Therapies

    ONK Therapeutics, Ltd. announced that the European Patent Office granted its licensed patent covering CISH knockout in natural killer (NK) cells, irrespective of the source of the NK cells, including human cord blood-derived, peripheral blood-derived, and NK cells derived from iPSCs.
    [ONK Therapeutics, Ltd.]

    Press Release
    FEATURED EVENT

    3rd Tumor Myeloid-Directed Therapies Summit

    July 18 – 20, 2023
    Boston, Massachusetts, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Researcher – Neurodegenerative Models Using iPSCs

    The Buck Institute – San Francisco, California, United States

    Research Manager – School of Mechanical and Materials Engineering

    University College Dublin – Dublin, Leinster, Ireland

    Lecturer – Bioengineering

    King’s College London – London, England, United Kingdom

    Postdoctoral Research Associate – Hematopoietic Stem and Progenitor cells

    University Hospital RWTH Aachen – Aachen, Germany

    Research Assistant – ESCs & Placenta

    The University of California San Francisco – San Francisco, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    ESC & iPSC News Twitter